congestive heart failure, peripheral artery disease , tracking the autonomic nervous system in young and elderly.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: For the experimental group : Congestive heart failure , cardiovascular disease, Chagas disease For the control group : not having cardiovascular disease and be over 18 years.
Exclusion criteria
Exclusion criteria: For the experimental group : New York Heart Association class I, hemodynamically decompensated patient , signs or symptoms of cardiovascular worsening in the last 3 months. For the control group : cardiovascular disease , hypertension, surgeries , fibromioalgia , dysautonomia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| improvement in physical function in cardiac by cardiopulmonary exercise test with at least 20 % of the increase from baseline in the experimental group . | — |
Secondary
| Measure | Time frame |
|---|---|
| Increased heart rate variability , verified by heart rate variability by at least 20 % of the initial value in the experimental group ; increased blood flow in the brachial artery verified by evaluating flow -mediated vasodilatation measured as a percentage , at least 20% of its initial value increased in the experimental group ; decrease of blood biochemical markers, the blood verified by examining at least 20 % decrease from baseline in experimental group ; | — |
Countries
Brazil
Contacts
Universidade de Brasília